Skip to content
Company Analysis

BioAge Labs, Inc. BIOA

A comprehensive view of key metrics, scores, and financial health for BioAge Labs, Inc.

Overview of BioAge Labs, Inc.

BIOA NMS
Healthcare Drug Manufacturers - Specialty & Generic Small Cap
BioAge Labs, Inc. (BIOA), is a Small Cap company, in the Drug Manufacturers - Specialty & Generic industry, last closed at $17.44, about 0.0% overvalued vs fair value, +315.2% 1Y return, ranked 875/1121 in sector.
$17.44
-3.43%
As of April 28, 2026
Previous close • Vol 90d: 93.5%
52-Week Range
Market Cap
$801.82M
Enterprise Value
$523.18M
Overall Score
View breakdown
Overall
Growth
Good
Profitability
Weak
Health
Weak
Efficiency
Fair
Valuation
Weak
Growth
Good
Profitability
Weak
Health
Weak
Efficiency
Fair
Valuation
Weak
Completeness: 76%
Confidence: 86%
Updated: Mar 8
Top Beats
No strong beats yet

Quick Facts

Website https://bioagelabs.com
HQ Richmond, CA
Employees 62
Fiscal year Dec 31

Next Events

Earnings May 5 Estimated

Fair Value Snapshot

Insufficient data
Show more details
  • Revenue data missing or non-positive

Engine Room Money Flow™

Small Cap

Pharmaceutical / Mature Biotech - Where revenue goes and how value is created

Flow Steps
Total Revenue
$0
R&D Expense
$59.0M
74.2%%
Operating Income (EBIT)
$-68.7M
-22.6%%
Operating Cash Flow
$-51.5M
-37.9%%
Money Flow Bridge
Flow Direction: Money moves from left to right
Components: Breakdown shows composition of each stage
Industry-Specific: Pharmaceutical / Mature Biotech

Where It Leaks

Cash Flow Health critical
Significant cash flow inefficiencies identified. Multiple high-impact leaks require attention.
2
Active Leaks
0/2
Improving
0
High Impact
2
Critical
Locked Leak
Upgrade to view details
Premium
Moat Analysis Corporate Default

Competitive Advantage Assessment

Evaluating BioAge Labs, Inc.'s durable competitive advantages across 6 defense dimensions

Overall Moat Strength
40
/100
Developing
Scores based on quantitative metrics and qualitative factors

Upgrade to unlock interactive defense details

Premium access

Unlock full defense analysis

Get key signals, strengths, and risks for every moat dimension.

Upgrade to Premium Unlock all moat defenses and evidence.

Pricing Power

Weak
0
Premium
Unlock full defense details

See key signals plus strengths and risks for this moat dimension.

Upgrade for full defense analysis Premium-only evidence and insights.
For informational purposes only. Not investment advice.

Trade-Off Ledger™

Where management spends the performance budget - Growth, Profitability, or Safety

Generic Industrial / Default vs Industry Peers 43% Coverage
Trade-Off Triangle Visualization A ternary plot showing BIOA's balance between Growth (30.6%), Profitability (24.1%), and Safety (45.3%). Growth 31% Safety 45% Profitability 24%

Click axes to expand details. Marker shows current allocation.

3-Year Trend Analysis Locked
Upgrade to unlock the full 3-year trend analysis and deltas.

Growth

- vs peers
-
Key Signals
EPS Growth YoY -1.09 19p
Strengths
  • Current Ratio in top 20% of peers (12.86, 98th percentile)
  • Strong liquidity position vs peers
Risks
  • EPS Growth YoY in bottom 20% of peers (-1.09)

Profitability

26th percentile vs peers
26
Key Signals
Strengths
Risks
Premium
Unlock full Profitability drilldowns

See the signal-level drivers and insights behind this axis. Upgrade to reveal the full Trade-Off Ledger.

Upgrade Now

Safety

49th percentile vs peers
49
Key Signals
Strengths
Safety drilldowns are available to premium members.

Two Futures

Scenario-based fair value ranges for BioAge Labs, Inc..

Loading valuation model...
Unable to Compute Fair Value

This company cannot be valued using standard models.

What this means: The Scenario Theatre requires financial data (revenue, cash flow, shares outstanding) to calculate fair value estimates. This data may be unavailable for:

  • Recently listed companies (IPOs, SPACs)
  • Shell companies or holding companies
  • Companies that haven't filed recent financials
  • Foreign companies with limited data coverage
X.X%
X%XX%
X.X%
-XX%XX%
XX.X%
-XX%XX%
Adjust the sliders above to explore different valuation scenarios.
Unlock Premium
Reveal the full Scenario Theatre
See live sliders, narratives, and full Bear/Base/Bull outcomes.
Upgrade Now
Bear
-
- - -
- upside
-
Base
-
- - -
- upside
-
Bull
-
- - -
- upside
-
Fair Value Range Current: $-
$- $- $-
Actions & Info